MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-PY-03-0016928
U S Biomedical Systems India Private Limited - life sciences in Puducherry, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹154.84 Cr
▲ 54% YoY
Net profit · FY 2025
₹10.8 Cr
Net margin 7%
EBITDA · FY 2025
₹26.63 Cr
EBITDA margin 17.2%
Authorised capital
₹80 Lakh
Registered with MCA
Paid-up capital
₹68.57 Lakh
Issued & subscribed
Company age
17 yrs
Est. 2009
Employees · EPFO
985
Provident fund records
Directors on board
2
As per MCA filings
About U S Biomedical Systems India Private Limited
Data last updated:
U S Biomedical Systems India Private Limited is a private limited company based in Puducherry, India, a subsidiary of Biomedical Systems Llc. Usa. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 22 December 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Pondicherry, under CIN U74900PY2009PTC002396. Its GSTIN is 34AABCU1334P1Z8 (Puducherry). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹80 Lakh and a paid-up capital of ₹68.57 Lakh. It is led by directors Aroul Mourougan Djealatchoumanan and Priyadarshini Yaravintelimath.
Its last annual general meeting (AGM) was held on 09 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Property No. 452A Bharathy Street, Puducherry, India – 605001.
As per the financials filed for FY 2025, the company reported a revenue of ₹154.84 Cr, a growth of 54% compared to the previous year. For the same year it recorded a net profit of ₹10.8 Cr (net margin 7%) and EBITDA of ₹26.63 Cr (EBITDA margin 17.2%). Revenue has grown at a compounded annual rate (CAGR) of 169% over three years and 193% over five years.
The company has about 985 employees on its provident fund (EPFO) records.
The company has 3 deals on record (2 secondary share transfers, 1 rights issue); the latest was in March 2022. Its 3 peer companies in the Business Services industry (Business Auxiliary Services), with the same principal business activity (other professional, scientific and technical activities) are compared by revenue, 1 larger and 2 smaller; the largest is Electrolux India Private Limited with revenue of ₹154.84 Cr.
U S Biomedical Systems India Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-PY-03-0016928). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sethdua.com.
Company details
CIN U74900PY2009PTC002396
Registration Number 002396
Incorporation Date 22 December 2009
ROC Pondicherry
Listing Status Unlisted
Company Status Active
Parent Company Biomedical Systems Llc. Usa
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-PY-03-0016928
Recognitions & Rankings of U S Biomedical Systems India
Contact details
U S Biomedical Systems India Private Limited's registered office is in Puducherry, Puducherry. Its website is sethdua.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressProperty No. 452A Bharathy Street, Puducherry, India – 605001
- IndustryLife Sciences, Biotechnology
To see the full contact details of U S Biomedical Systems India Private Limited, buy the company report.
Comprehensive company report
U S Biomedical Systems India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of U S Biomedical Systems India is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of U S Biomedical Systems India Private Limited, buy the company report.
Financials of U S Biomedical Systems India Private Limited
FY 2025 filings availableU S Biomedical Systems India Private Limited reported revenue of ₹154.84 Cr (up 54% YoY) for FY 2025.
Revenue · FY 2025
₹154.84 Cr ▲ 54%
Net profit · FY 2025
₹10.8 Cr margin 7%
EBITDA · FY 2025
₹26.63 Cr margin 17.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 54%
3 years · compounded
▲ 169%
5 years · compounded
▲ 193%
EBITDA CAGR growth
1 year
▲ 34%
3 years · compounded
▲ 195%
5 years · compounded
▲ 219%
Revenue has grown at a compounded annual rate (CAGR) of 193% over five years, including 54% growth in the latest year. EBITDA rose 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹26.63 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.8 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.2% | ||||
| Net Profit Margin | 7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of U S Biomedical Systems India Private Limited, buy the company report.
Board of directors of U S Biomedical Systems India Private Limited
U S Biomedical Systems India has 2 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aroul Mourougan Djealatchoumanan | Director | 01 Apr 2014 | 12 Years 7 Months | Current |
| Priyadarshini Yaravintelimath | Director | 20 Nov 2023 | 2 Years 11 Months | Current |
Peer comparison
U S Biomedical Systems India Private Limited is compared with the 3 companies closest to it by revenue in the Business Services industry (Business Auxiliary Services), with the same principal business activity (other professional, scientific and technical activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Electrolux India Private Limited | ₹154.84 Cr (FY 2025) | 90.0% | Gurugram, Haryana, India | |||
| U S Biomedical Systems India Private Limitedthis company | ₹154.84 Cr (FY 2025) | ₹10.8 Cr | 7% | 54.0% | 985 | Puducherry, India |
| Ephicacy Lifescience Analytics Private Limited | ₹153.95 Cr (FY 2025) | 9.0% | Bangalore, Karnataka, India | |||
| Blackberry India Private Limited | ₹153.73 Cr (FY 2025) | 71.0% | New Delhi, Delhi, India |
To see the full peer comparison of U S Biomedical Systems India Private Limited, buy the company report.
Auditor
U S Biomedical Systems India Private Limited is audited by Chandabhoy & Jassoobhoy for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Chandabhoy & Jassoobhoy | FY 2023 | 101647W |
Shareholding
The shareholding of U S Biomedical Systems India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of U S Biomedical Systems India Private Limited, buy the company report.
Deals & funding
U S Biomedical Systems India Private Limited has 3 deals on record (2 secondary share transfers, 1 rights issue); the latest was in March 2022.
Total deals
3
Secondary share transfers
2
Rights issue
1
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: Ert Technology Company Llc Seller: an individual |
| Mar 2022 | Rights issue | ₹30.75 Cr | Investors: Biomedical Systems Llc |
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: Biomedical Systems Llc, an individual Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving U S Biomedical Systems India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for U S Biomedical Systems India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
U S Biomedical Systems India Private Limited has a workforce of 985 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.
Employee count
985
Active EPFO establishments
2
Employee growth
16.4%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 985 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 |
To see the full employee and EPFO history of U S Biomedical Systems India Private Limited, buy the company report.
GST
U S Biomedical Systems India has 3 GST registrations: 3 active.
Total GSTINs
3
Active
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 34AABCU1334P1Z8 | Puducherry | Active | 04 Mar 2022 |
| 34AABCU1334P2Z7 | Puducherry | Active | 01 Apr 2025 |
| 29AABCU1334P1ZZ | Karnataka | Active | 17 Mar 2022 |
To see the full GST registrations and return filing status of U S Biomedical Systems India Private Limited, buy the company report.
Recent activity
U S Biomedical Systems India Private Limited has 14 board changes on record since 2010: 2 appointments and 12 cessations. The latest: Priyadarshini Yaravintelimath ceased to be Additional Director on 29 Sep 2024.
AGM
U S Biomedical Systems India Private Limited last Annual general meeting of members was held on 09 Sep 2025 as per latest MCA records.
Filing
U S Biomedical Systems India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pondicherry.
Ceased
Priyadarshini Yaravintelimath ceased to be Additional Director.
Ceased
Daniel S Braem ceased to be Additional Director.
Appointed
Priyadarshini Yaravintelimath was appointed as Director.
Ceased
Christopher Charles Fikry ceased to be Additional Director.
Ceased
Michael John Bonello ceased to be Additional Director.
Ceased
Joseph Franklin Eazor ceased to be Additional Director.
Ceased
James Corrigan Michael ceased to be Additional Director.
Ceased
Waqar Nasim ceased to be Additional Director.
Ceased
Daniel Gerard Barrett ceased to be Director.
Appointed
Aroul Mourougan Djealatchoumanan was appointed as Director.
5 earlier events are in the company report.
Frequently asked questions
U S Biomedical Systems India is an active private limited company based in Puducherry, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 22 December 2009 (17+ years old) and is registered under CIN U74900PY2009PTC002396.
U S Biomedical Systems India has 2 current directors:
- Aroul Mourougan Djealatchoumanan - Director
- Priyadarshini Yaravintelimath - Director
The latest financial statements of U S Biomedical Systems India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 09 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of U S Biomedical Systems India is 34AABCU1334P1Z8, registered in Puducherry. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 34AABCU1334P2Z7 (Puducherry), 29AABCU1334P1ZZ (Karnataka).
The CIN (Corporate Identification Number) of U S Biomedical Systems India is U74900PY2009PTC002396. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
U S Biomedical Systems India was incorporated on 22 December 2009, making it 17+ years old. It is registered with the Registrar of Companies, Pondicherry.
U S Biomedical Systems India has 3 deals on record (2 secondary share transfers, 1 rights issue); the latest was in March 2022.
The peers of U S Biomedical Systems India by revenue are Electrolux India Private Limited, Ephicacy Lifescience Analytics Private Limited, Blackberry India Private Limited, all in the Business Services industry (Business Auxiliary Services), with the same principal business activity (other professional, scientific and technical activities).
Priyadarshini Yaravintelimath ceased to be Additional Director on 29 Sep 2024. Daniel S Braem ceased to be Additional Director on 16 Sep 2024. Priyadarshini Yaravintelimath was appointed as Director on 20 Nov 2023. U S Biomedical Systems India has 14 board changes on record in total.
Yes, U S Biomedical Systems India is registered as an MSME under Udyam registration (number: UDYAM-PY-03-0016928).
U S Biomedical Systems India can be reached through the website sethdua.com. Its registered office is in Puducherry, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages